AI Model Predicts Cancer Survival and Biological Age from a Single Facial Photograph

Reviewed byNidhi Govil

14 Sources

Share

Researchers at Mass General Brigham developed FAHR-Face, an AI model trained on over 40 million images that predicts cancer survival outcomes and biological age from facial photographs. In the highest-risk group, 52% of patients died within 90 days, while only 2.1% in the lowest-risk category faced similar outcomes.

AI Model Analyzes Facial Features to Assess Cancer Patient Health

Researchers at Mass General Brigham Cancer Institute have developed FAHR-Face (Foundation Artificial Intelligence for Health Recognition), an AI model trained on over 40 million facial photographs that can predict cancer survival outcomes and estimate biological age from a single image

1

3

. The foundation model uses self-supervised learning through masked autoencoders to learn facial patterns before being fine-tuned into two distinct tools: FAHR-FaceAge for biological age estimation and FAHR-FaceSurvival for direct survival risk prediction

2

5

. Published in The Lancet Digital Health, this research represents the first demonstration that an AI model can directly predict cancer survival from a simple photograph

3

.

Source: Inc.

Source: Inc.

Distinct Facial Regions Reveal Different Health Insights

The two AI facial health recognition tools analyze different facial areas to extract complementary health information. FAHR-FaceAge focuses on nasolabial folds, the forehead area just above the orbits, and the temples to estimate biological age

3

5

. Meanwhile, FAHR-FaceSurvival evaluates the region below the eyes and around the nasal bridge to assess mortality risk

1

3

. Using attention mapping techniques, researchers tracked where the algorithm focused its analysis, though the exact biological mechanisms linking these facial features to survival outcomes remain unclear

1

.

Source: Scientific American

Source: Scientific American

Accuracy Metrics Show Promising Results Across Patient Groups

FAHR-FaceAge achieved a mean absolute error of 5.1 years when estimating chronological age in public image datasets, outperforming benchmark models with 6.92-year errors

2

5

. The biological age predictions carried significant prognostic insights: patients who appeared five or more years older than their actual age had a 21% higher risk of mortality, while those looking five years younger showed 17% higher survival rates

5

. FAHR-FaceSurvival demonstrated even more striking results in a test group of 3,820 cancer patients, where 52% of those in the highest-risk category died within 90 days, compared to only 2.1% in the lowest-risk group

4

5

. In another cohort, 64 out of 122 patients with the highest risk scores died within 90 days of their photograph being taken

1

.

Lifestyle Factors Influence Facial Aging Patterns

The research revealed connections between lifestyle choices and facial aging. Heavy alcohol use, drug use, and smoking were associated with looking biologically older than chronological age

3

. Smoking showed the strongest pattern, with current smokers appearing older than former smokers, who in turn looked older than people who had never smoked

3

. The AI model demonstrated robustness across common photo variations including makeup, lighting, facial expression, and pose

1

4

. Most plastic surgery procedures did not significantly affect age predictions, with rhinoplasty being the notable exception—the AI model tended to rate people who had nose jobs as slightly older in post-surgery images

1

4

.

Clinical Applications Target Personalized Treatment Decisions

According to Raymond Mak, radiation oncologist at Mass General Brigham Cancer Institute and corresponding author, the goal is to make facial photograph-based health assessment more quantitative, consistent, and scalable to support personalized treatment decisions rather than replace physician judgment

3

4

. The AI model builds on how doctors evaluate patients during clinical decision-making, transforming subjective visual assessments into objective measurements

1

. As the population ages, physicians need better ways to estimate physical reserve and frailty before recommending intensive treatments such as radiation, surgery, or systemic therapy

3

4

. Mass General Brigham has a patent pending for these facial health algorithms

1

.

Source: News-Medical

Source: News-Medical

Validation Challenges and Diversity Concerns Remain

The cancer survival model was trained primarily on a Boston-area cancer patient population that was majority white, raising concerns about generalizability

1

. Researchers are working to expand their training sets to include diverse training data from different ethnic groups

1

4

. The team tested the model across two independent clinical cohorts: 38,183 patients treated at Harvard-affiliated radiotherapy centers in the United States and 4,892 cancer patients who received radiotherapy in the Netherlands

2

. Prof. Miroslaw Bober from the University of Surrey cautioned that while this is a promising proof of concept, the tool needs testing against doctors' own judgment and across different hospitals and patient groups before clinical use

4

.

Ethical Concerns and Future Development Path

Matthew Liao, professor and director of the Center for Bioethics at New York University, noted that while the research was interesting and could help identify patients needing extra care, ethical concerns exist around AI algorithms potentially misidentifying patients as healthy or sick

1

. The researchers are expanding their work through the FaceAge Research Study, an institutional review board-approved online study open to the public where participants can upload facial photographs and receive their own biological age readout while contributing data to improve validation across larger and more diverse populations

3

5

. Hugo Aerts, co-senior author and director of AI in Medicine at Mass General Brigham, emphasized that this foundation-model approach provides a scalable way to develop multiple facial health biomarkers and non-invasive biomarkers rather than training each model from scratch

3

5

.

Today's Top Stories

© 2026 TheOutpost.AI All rights reserved